Table 2 Clinicopathological data of the patients participating in this study.
Variables (n = 310) | Number (n) | Percentage (%) |
|---|---|---|
Age (year) at diagnosis | ||
≤ 40 | 85 | 27.42 |
> 40 | 225 | 72.58 |
Histologic type | ||
IDC | 298 | 96.13 |
ILC | 12 | 3.87 |
Receptor status | ||
ER+ | 310 | 100 |
ER− | 0 | 0 |
PR+ | 310 | 100 |
PR− | 0 | 0 |
HER2+ | 162 | 52.26 |
HER2− | 148 | 47.74 |
Tumor size | ||
T1 (< 2 cm) | 47 | 15.16 |
T2 (≥ 2 and ≤ 5 cm) | 198 | 63.87 |
T3 (> 5 cm) | 65 | 20.97 |
Grading of tumor | ||
G1 | 31 | 10.00 |
G2 | 184 | 59.35 |
G3 | 95 | 30.65 |